Maegim

Stock search

Search by company name, 6-digit code, or Korean initials (e.g. ㅅㅅㅈㅈ)

☆한국어

Hanmi Pharm. Co., Ltd.

한미약품128940KOSPISector: Pharma & Biotech
₩473,5002.82%Market cap ₩6.07TAs of Sep 4, 2026 close · updated once daily
Market cap
₩6.07T
#90 in KOSPI
35.8x
Sector median 15.7x (profitable cos.)
4.85x
Sector median 1.59x
0.4%
Sector median 0.0%
B
Grade B59.3 ptsTop 35% of 2,522 graded stocksMethodology v2.0
Financial strength
69.0/100
Growth momentum
57.9/100
Price attractiveness
46.2/100
Shareholder Return
78.5/100

As of Sep 4, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

How to read this grade
SABCurrentCDF

Toward S means a higher total-score band; toward F, a lower band. Badges are distinguished by ink intensity and shape (fill, outline, dashed) — never by hue.

Maegim maps a total score — built from sector-relative percentile scoring — onto fixed, predefined thresholds to assign one of six bands, S to F. This stock is scored by the same formula as all 2,522 graded stocks and is currently in band B with a total score of 59.3 points.

How grades are computed →What grades do and don’t mean →What the grade does not reflect →

Position within sector

Mechanically selected indicators in the top or bottom 30% of sector percentiles · among 250 stocks in Pharma & Biotech

1-year closing price

Loading closing price history…
 
Low ₩290,500High ₩626,000
Latest close
Price change by period
1W
6.90%
1M
25.20%
3M
3.60%
1Y
55.50%

As of the Sep 4, 2026 close · updated once daily · a factual record computed from closing prices only; dividends are not included, and this is not a buy or sell signal.

1

Financial strength

69.0/100
How much debt does it carry relative to equity?
50.2%
Sector median 51.6%
Sector lowhighTop 48% in sector
Can it cover what's due within a year?
147.7%
Sector median 191.7%
Sector lowhighBottom 41.1% in sector
How much of revenue becomes profit?
16.7%
Sector median -2.4%
Sector lowhighTop 9.6% in sector
How much did it earn on its own capital?
13.6%
Sector median -4.5%
Sector lowhighTop 7.5% in sector

Source filing: annual report (consolidated) — view original ↗

2

Growth momentum

57.9/100
How much did revenue grow in a year?
3.5%
Sector median 6.4%
Sector lowhighBottom 40.7% in sector
Has it grown steadily over three years?
5.1%
Sector median 4.9%
Sector lowhighTop 49.2% in sector
Did core profits grow in a year?
19.2%
Sector median 3.6%
Sector lowhighTop 37.1% in sector
Are core profits higher than three years ago?
63.1%
Sector median 3.5%
Sector lowhighTop 22.8% in sector

Financial trend

Revenue

Growth & margin

Revenue growth Operating margin

Year over year — alongside the sector median

This stock Sector median

A factual chart of confirmed annual results from annual reports — the same source as the grading indicators. Not a buy or sell signal.

Source filing: annual report (consolidated) — view original ↗

3

Price attractiveness

46.2/100
Is the price expensive relative to earnings?
35.8x
Sector median P/E of profitable peers 15.7x · 58% loss-making
Sector lowhighTop 32.6% in sector
Is the price expensive relative to book value?
4.85x
Sector median 1.59x
Sector lowhighBottom 24.9% in sector

Valuation uses the Sep 4, 2026 close and market cap

4

Shareholder Return

Single-indicator axis78.5/100
Does the company actually pay dividends?
0.4%
Sector median 0.0%
Sector lowhighTop 21.5% in sector

Dividend per share (annual)

Cash dividend per common share as stated in annual reports. ₩0 means no dividend that year.

Dividends & treasury shares

Total cash dividends (FY2025)
₩25.4B
Cash payout ratio, consolidated (FY2025)
14.6%
Treasury shares (FY2025)
130,777 shares (1.0% of shares issued)

Source: annual report (DART) — dividend allocation & total shares

Source filing: annual report (consolidated) — view original ↗

Financial checklist

Based on the FY2025 annual report · year-over-year comparison · determined on Sep 7, 2026

Of 9 items: 8 met · 1 not met · 0 not computable

Not metMetNot computable

Positive net income
Whether net income (attributable to owners where available) is above zero.
Met
₩169.6B
Positive operating cash flow
Whether cash flow from operations is above zero.
Met
₩173.1B
Return on assets up
Whether net income over beginning total assets rose from the prior year.
Met
6.4% → 8.4%
Operating cash flow exceeds net income
Whether operating cash flow is greater than net income.
Met
₩173.1B vs ₩169.6B
Liabilities-to-assets ratio down
Whether total liabilities as a share of total assets fell from the prior year.
Met
38.6% → 33.4%
Current ratio up
Whether current assets over current liabilities rose from the prior year.
Met
109.3% → 147.7%
Shares outstanding not increased
Whether common shares issued did not increase from the prior year. Increases from bonus issues and stock dividends are also counted.
Met
12,810,991 → 12,810,991
Operating margin up
Whether operating income over revenue rose from the prior year.
Met
14.5% → 16.7%
Asset turnover up
Whether revenue over beginning total assets rose from the prior year.
Not met
0.79x → 0.77x

A record of facts determined by fixed rules from the financial statements in the latest annual report. Not used in grading, and not a buy or sell signal. Source filing: annual report (consolidated) — view original ↗

Grade change history

Jul 23, 2026B

Methodology version change (v2.0 applied)

Jul 15, 2026BVersion v1

First calculation

Grade changes are a factual record produced from public data by a fixed formula; they do not signal future changes.

Disclosure & financial badges

Factual records determined from public filings and periodic reports by fixed rules — not buy/sell signals.

Negative-evidence group (dilution, loss, dispute)Mixed interpretationPositive-evidence group (shareholder return)Dots classify the disclosure type by the direction of research evidence — not an assessment or investment judgment about this company.

Disclosure event history

Corporate value-up plan filed

Filed a “기업가치제고계획(자율공시)” (corporate value-up plan, voluntary disclosure) (filed 2025-12-04). View filing ↗

Determined as of 2026-09-07

Recent filings for this stock

Last 120 days · monitored filing types only
Periodic report filedAug 14, 2026Source ↗
Treasury stock disposalJul 28, 2026Source ↗
Periodic report filedMay 15, 2026Source ↗

View in the filings calendar →